{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:01Z","timestamp":1790805301478,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T00:00:00Z","timestamp":1391817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00109-014-1127-4","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T03:59:36Z","timestamp":1391745576000},"page":"641-650","source":"Crossref","is-referenced-by-count":44,"title":["Correction of glycogen storage disease type III with rapamycin in a canine model"],"prefix":"10.1007","volume":"92","author":[{"given":"Haiqing","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Fyfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,8]]},"reference":[{"key":"1127_CR1","first-page":"446","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, Chung WK, Desai DM, El-Gharbawy A, Haller R et al (2010) Glycogen storage disease type III diagnosis and management guidelines. Genet Med Off J Am Coll Med Genet 12:446\u2013463","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"1127_CR2","volume-title":"Scriver\u2019s online metabolic & molecular bases of inherited disease","author":"YT Chen","year":"2009","unstructured":"Chen YT, Kishnani PS, Koeberl DD (2009) Glycogen storage diseases. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A (eds) Scriver\u2019s online metabolic & molecular bases of inherited disease. McGraw-Hill, New York"},{"key":"1127_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","volume":"46","author":"E Demo","year":"2007","unstructured":"Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS (2007) Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol 46:492\u2013498","journal-title":"J Hepatol"},{"key":"1127_CR4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0210-5705(05)71526-0","volume":"28","author":"A Cosme","year":"2005","unstructured":"Cosme A, Montalvo I, Sanchez J, Ojeda E, Torrado J, Zapata E, Bujanda L, Gutierrez A, Arenas I (2005) Type III glycogen storage disease associated with hepatocellular carcinoma. Gastroenterol Hepatol 28:622\u2013625","journal-title":"Gastroenterol Hepatol"},{"key":"1127_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/hep.510250307","volume":"25","author":"EB Haagsma","year":"1997","unstructured":"Haagsma EB, Smit GP, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ (1997) Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 25:537\u2013540","journal-title":"Hepatology"},{"key":"1127_CR6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF01800225","volume":"15","author":"RA Coleman","year":"1992","unstructured":"Coleman RA, Winter HS, Wolf B, Chen YT (1992) Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features. J Inherit Metab Dis 15:869\u2013881","journal-title":"J Inherit Metab Dis"},{"key":"1127_CR7","unstructured":"Lucchiari S, Santoro D, Pagliarani S, Comi GP (2007) Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency. Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology\/edited by the Gaetano Conte Academy for the study of striated muscle diseases 26:72\u201374"},{"key":"1127_CR8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ajmg.1320420514","volume":"42","author":"T Momoi","year":"1992","unstructured":"Momoi T, Sano H, Yamanaka C, Sasaki H, Mikawa H (1992) Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 42:696\u2013699","journal-title":"Am J Med Genet"},{"key":"1127_CR9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/hrt.34.8.862","volume":"34","author":"CG Miller","year":"1972","unstructured":"Miller CG, Alleyne GA, Brooks SE (1972) Gross cardiac involvement in glycogen storage disease type 3. Br Heart J 34:862\u2013864","journal-title":"Br Heart J"},{"key":"1127_CR10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/0002-9149(84)90551-4","volume":"53","author":"LJ Olson","year":"1984","unstructured":"Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV (1984) Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 53:980\u2013981","journal-title":"Am J Cardiol"},{"key":"1127_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/BF00443106","volume":"148","author":"SW Moses","year":"1989","unstructured":"Moses SW, Wanderman KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148:764\u2013766","journal-title":"Eur J Pediatr"},{"key":"1127_CR12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0002-9149(96)00885-5","volume":"79","author":"PJ Lee","year":"1997","unstructured":"Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV (1997) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79:834\u2013838","journal-title":"Am J Cardiol"},{"key":"1127_CR13","doi-asserted-by":"crossref","unstructured":"Yi H, Thurberg BL, Curtis S, Austin S, Fyfe J, Koeberl DD, Kishnani PS, Sun B (2012) Characterization of a canine model of glycogen storage disease type IIIa. Dis Model Mech 5:804\u2013811. doi: 10.1242\/dmm.009712","DOI":"10.1242\/dmm.009712"},{"key":"1127_CR14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","volume":"40","author":"S Sengupta","year":"2010","unstructured":"Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40:310\u2013322","journal-title":"Mol Cell"},{"key":"1127_CR15","first-page":"133","volume":"23","author":"L Rostaing","year":"2010","unstructured":"Rostaing L, Kamar N (2010) mTOR inhibitor\/proliferation signal inhibitors: entering or leaving the field? J Nephrol 23:133\u2013142","journal-title":"J Nephrol"},{"key":"1127_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ceb.2009.01.024","volume":"21","author":"P Polak","year":"2009","unstructured":"Polak P, Hall MN (2009) mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21:209\u2013218","journal-title":"Curr Opin Cell Biol"},{"key":"1127_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","volume":"12","author":"CK Tsang","year":"2007","unstructured":"Tsang CK, Qi H, Liu LF, Zheng XF (2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12:112\u2013124","journal-title":"Drug Discov Today"},{"key":"1127_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BST0370213","volume":"37","author":"DC Goberdhan","year":"2009","unstructured":"Goberdhan DC, Boyd CA (2009) mTOR: dissecting regulation and mechanism of action to understand human disease. Biochem Soc Trans 37:213\u2013216","journal-title":"Biochem Soc Trans"},{"key":"1127_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","volume":"23","author":"E Dazert","year":"2011","unstructured":"Dazert E, Hall MN (2011) mTOR signaling in disease. Curr Opin Cell Biol 23:744\u2013755","journal-title":"Curr Opin Cell Biol"},{"key":"1127_CR20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.metabol.2006.08.002","volume":"55","author":"IJ Sipula","year":"2006","unstructured":"Sipula IJ, Brown NF, Perdomo G (2006) Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Metab Clin Exp 55:1637\u20131644","journal-title":"Metab Clin Exp"},{"key":"1127_CR21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.yexcr.2007.12.019","volume":"314","author":"S Varma","year":"2008","unstructured":"Varma S, Shrivastav A, Changela S, Khandelwal RL (2008) Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt\/PKB and glycogen synthase activity. Exp Cell Res 314:1281\u20131291","journal-title":"Exp Cell Res"},{"key":"1127_CR22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2010.05.001","volume":"100","author":"KM Ashe","year":"2010","unstructured":"Ashe KM, Taylor KM, Chu Q, Meyers E, Ellis A, Jingozyan V, Klinger K, Finn PF, Cooper CG, Chuang WL et al (2010) Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease. Mol Genet Metab 100:309\u2013315","journal-title":"Mol Genet Metab"},{"key":"1127_CR23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2010.10.044","volume":"55","author":"E Patsenker","year":"2011","unstructured":"Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C, Stickel F (2011) Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol 55:388\u2013398","journal-title":"J Hepatol"},{"key":"1127_CR24","first-page":"1315","volume":"15","author":"KR Bridle","year":"2009","unstructured":"Bridle KR, Popa C, Morgan ML, Sobbe AL, Clouston AD, Fletcher LM, Crawford DH (2009) Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 15:1315\u20131324","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"1127_CR25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","volume":"45","author":"M Neef","year":"2006","unstructured":"Neef M, Ledermann M, Saegesser H, Schneider V, Reichen J (2006) Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. J Hepatol 45:786\u2013796","journal-title":"J Hepatol"},{"key":"1127_CR26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","volume":"313","author":"E Biecker","year":"2005","unstructured":"Biecker E, De Gottardi A, Neef M, Unternahrer M, Schneider V, Ledermann M, Sagesser H, Shaw S, Reichen J (2005) Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. J Pharmacol Exp Ther 313:952\u2013961","journal-title":"J Pharmacol Exp Ther"},{"key":"1127_CR27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","volume":"117","author":"J Zhu","year":"1999","unstructured":"Zhu J, Wu J, Frizell E, Liu SL, Bashey R, Rubin R, Norton P, Zern MA (1999) Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 117:1198\u20131204","journal-title":"Gastroenterology"},{"key":"1127_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2012.12.002","volume":"108","author":"B Sun","year":"2013","unstructured":"Sun B, Fredrickson K, Austin S, Tolun AA, Thurberg BL, Kraus WE, Bali D, Chen YT, Kishnani PS (2013) Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III. Mol Genet Metab 108:145\u2013147","journal-title":"Mol Genet Metab"},{"key":"1127_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","volume":"53","author":"CM Lynch","year":"2005","unstructured":"Lynch CM, Johnson J, Vaccaro C, Thurberg BL (2005) High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology. J Histochem Cytochem Off J Histochem Soc 53:63\u201373","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"key":"1127_CR30","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1093\/hmg\/ddn290","volume":"17","author":"G Douillard-Guilloux","year":"2008","unstructured":"Douillard-Guilloux G, Raben N, Takikita S, Batista L, Caillaud C, Richard E (2008) Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II. Hum Mol Genet 17:3876\u20133886","journal-title":"Hum Mol Genet"},{"key":"1127_CR31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","volume":"6","author":"C Mammucari","year":"2007","unstructured":"Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J et al (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6:458\u2013471","journal-title":"Cell Metab"},{"key":"1127_CR32","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/cancers3022630","volume":"3","author":"S Sridharan","year":"2011","unstructured":"Sridharan S, Jain K, Basu A (2011) Regulation of autophagy by kinases. Cancers 3:2630\u20132654","journal-title":"Cancers"},{"key":"1127_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jgm.242","volume":"4","author":"R Safadi","year":"2002","unstructured":"Safadi R, Friedman SL (2002) Hepatic fibrosis\u2014role of hepatic stellate cell activation. Med Gen Med 4:27","journal-title":"Med Gen Med"},{"key":"1127_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25:195\u2013206","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1127_CR35","first-page":"2087","volume":"14","author":"SH Sacks","year":"1999","unstructured":"Sacks SH (1999) Rapamycin on trial. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 14:2087\u20132089","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc"},{"key":"1127_CR36","first-page":"18","volume":"16","author":"E Morelon","year":"2001","unstructured":"Morelon E, Mamzer-Bruneel MF, Peraldi MN, Kreis H (2001) Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 16:18\u201320","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-014-1127-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1127-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:27:44Z","timestamp":1558585664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-014-1127-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,8]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1007\/s00109-014-1127-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,8]]}}}